BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRTS
2901
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $16.3M | ﹤0.01% |
2,454,874
+275,194
| +13% | +$1.85M |
|
2902
Cadiz
CDZI
$297M
| $16.2M | ﹤0.01% |
1,599,355
+482,821
| +43% | +$5.39M |
|
2903
Invesco S&P 500 Quality ETF
SPHQ
$20.1B
| $16.2M | ﹤0.01% |
457,424
| – | – |
|
|
CHMA
2904
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $16.1M | ﹤0.01% |
3,000,923
+446,180
| +17% | +$2.46M |
|
2905
iShares Currency Hedged MSCI Japan ETF
HEWJ
$769M
| $16.1M | ﹤0.01% |
524,905
-300,053
| -36% | -$8.81M |
|
2906
First Bancorp
FNLC
$402M
| $16M | ﹤0.01% |
739,177
-6,638
| -0.9% | -$137K |
|
2907
Limoneira
LMNR
$250M
| $16M | ﹤0.01% |
1,104,698
+16,183
| +1% | +$213K |
|
|
RVI
2908
DELISTED
Retail Value Inc. Common Shares
RVI
| $16M | ﹤0.01% |
14,099,826
+1,013,301
| +8% | +$1.15M |
|
2909
Global Indemnity Group
GBLI
$409M
| $16M | ﹤0.01% |
666,332
+19,753
| +3% | +$472K |
|
|
STSA
2910
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $15.9M | ﹤0.01% |
551,366
+337,754
| +158% | +$7.82M |
|
2911
Lifecore Biomedical
LFCR
$179M
| $15.8M | ﹤0.01% |
1,990,148
-33,432
| -2% | -$345K |
|
|
FRTA
2912
DELISTED
Forterra, Inc
FRTA
| $15.8M | ﹤0.01% |
1,418,059
-95,126
| -6% | -$785K |
|
|
SCU
2913
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $15.7M | ﹤0.01% |
1,217,582
+83,209
| +7% | +$1.07M |
|
2914
W&T Offshore
WTI
$548M
| $15.7M | ﹤0.01% |
6,899,105
-121,342
| -2% | -$308K |
|
|
EXPR
2915
DELISTED
Express, Inc.
EXPR
| $15.7M | ﹤0.01% |
510,726
-4,617
| -0.9% | -$170K |
|
2916
HBT Financial
HBT
$1.35B
| $15.7M | ﹤0.01% |
1,179,692
+64,143
| +6% | +$769K |
|
|
CSPR
2917
DELISTED
Casper Sleep Inc.
CSPR
| $15.7M | ﹤0.01% |
1,753,095
+214,722
| +14% | +$1.52M |
|
2918
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.8B
| $15.7M | ﹤0.01% |
165,090
+35,114
| +27% | +$3.23M |
|
|
AVID
2919
DELISTED
Avid Technology Inc
AVID
| $15.7M | ﹤0.01% |
2,157,862
+179,996
| +9% | +$1.19M |
|
2920
Descartes Systems
DSGX
$6.62B
| $15.7M | ﹤0.01% |
296,432
+25,956
| +10% | +$1.15M |
|
2921
iShares Emerging Markets Dividend ETF
DVYE
$1.21B
| $15.6M | ﹤0.01% |
498,339
-600,972
| -55% | -$18.6M |
|
2922
Clear Channel Outdoor Holdings
CCO
$1.19B
| $15.6M | ﹤0.01% |
15,003,455
-2,248,665
| -13% | -$2.11M |
|
2923
iShares MSCI Netherlands ETF
EWN
$734M
| $15.6M | ﹤0.01% |
476,910
-409,471
| -46% | -$12.1M |
|
2924
CNB Financial Corp
CCNE
$1.03B
| $15.6M | ﹤0.01% |
869,767
+35,575
| +4% | +$602K |
|
2925
Greenlight Captial
GLRE
$512M
| $15.6M | ﹤0.01% |
2,390,383
-10,339
| -0.4% | -$67.6K |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.